SPECTRAL Financial Statements From 2010 to 2025
| SD4 Stock | EUR 0.36 0.01 2.86% |
Check SPECTRAL MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SPECTRAL MEDICAL's main balance sheet or income statement drivers, such as , as well as many indicators such as . SPECTRAL financial statements analysis is a perfect complement when working with SPECTRAL MEDICAL Valuation or Volatility modules.
SPECTRAL |
SPECTRAL MEDICAL Company Return On Equity Analysis
SPECTRAL MEDICAL's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current SPECTRAL MEDICAL Return On Equity | -7.84 |
Most of SPECTRAL MEDICAL's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SPECTRAL MEDICAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, SPECTRAL MEDICAL has a Return On Equity of -7.8381. This is 67.3% lower than that of the Healthcare sector and 17.34% higher than that of the Diagnostics & Research industry. The return on equity for all Germany stocks is notably higher than that of the company.
SPECTRAL MEDICAL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SPECTRAL MEDICAL's current stock value. Our valuation model uses many indicators to compare SPECTRAL MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SPECTRAL MEDICAL competition to find correlations between indicators driving SPECTRAL MEDICAL's intrinsic value. More Info.SPECTRAL MEDICAL is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SPECTRAL MEDICAL's earnings, one of the primary drivers of an investment's value.About SPECTRAL MEDICAL Financial Statements
SPECTRAL MEDICAL stakeholders use historical fundamental indicators, such as SPECTRAL MEDICAL's revenue or net income, to determine how well the company is positioned to perform in the future. Although SPECTRAL MEDICAL investors may analyze each financial statement separately, they are all interrelated. For example, changes in SPECTRAL MEDICAL's assets and liabilities are reflected in the revenues and expenses on SPECTRAL MEDICAL's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in SPECTRAL MEDICAL. Please read more on our technical analysis and fundamental analysis pages.
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 18 people.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in SPECTRAL Stock
SPECTRAL MEDICAL financial ratios help investors to determine whether SPECTRAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SPECTRAL with respect to the benefits of owning SPECTRAL MEDICAL security.